文献速递胸部肿瘤放疗放疗物理与技术

晚期非小细胞肺癌心肺系统剂量与放疗后心电图异常的关系

Dose to the cardio-pulmonary system and treatment-induced electrocardiogram abnormalities in locally advanced non-small cell lung cancer.
PubMed 文献 · Clin Transl Radiat Oncol · 2019-09-21

本研究分析155例局部晚期非小细胞肺癌患者放疗前后心电图,中位剂量64 Gy,采用调强放疗联合化疗。结果显示放疗后中位8个月时新发心律失常、缺血/心包及非特异性心电图异常率分别为66%、35%、67%;非特异性异常与上腔静脉最低剂量较高相关,心律失常和缺血/心包异常与较差体能状态相关。

要点

  • 放疗后非特异性心电图异常与上腔静脉最低剂量较高相关。
  • 心律失常和缺血/心包异常与较差体能状态相关。
  • 减少心肺系统剂量可能降低放疗诱导的心脏毒性。

核心结论

  • 心肺系统较高放疗剂量可能导致非特异性心电图异常。
  • 在有效控制肿瘤的同时降低该区域剂量,可能减少放疗诱导的心脏毒性。

研究设计与样本

  • 回顾性分析2004至2014年155例局部晚期非小细胞肺癌患者,中位剂量64 Gy,分次1.8-2.0 Gy,调强放疗联合化疗(同步64%、序贯36%)。
  • 分析放疗前后心电图,将异常分类为新发心律失常、缺血/心包或非特异性事件,采用竞争风险模型(死亡为竞争风险)评估剂量体积指标与异常的关系。

主要发现

  • 放疗后中位8个月时,新发心律失常、缺血/心包及非特异性心电图异常率分别为66%、35%、67%。
  • 心律失常和缺血/心包异常均与较差体能状态相关(p=0.007,0.03)。
  • 上腔静脉最低剂量较高与非特异性心电图异常相关(p=0.002)。

关键数值与推荐

  • 分次校正剂量体积指标采用α/β=3 Gy。
  • 候选预测因子通过1000次自举样本的中位多重检验校正p值≤0.05确定。

临床怎么用

  • 对局部晚期非小细胞肺癌放疗计划,可关注上腔静脉最低剂量等心肺系统剂量参数。
  • 放疗后随访中可考虑心电图监测,尤其对体能状态较差患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: High dose radiotherapy (RT) has been associated with unexpectedly short survival times for locally advanced Non-Small Cell Lung Cancer (LA-NSCLC) patients. Here we tested the hypothesis that cardiac substructure dose is associated with electrocardiography (ECG) assessed abnormalities after RT for LA-NSCLC. MATERIALS AND METHODS: Pre- and post-RT ECGs were analyzed for 155 LA-NSCLC patients treated to a median of 64 Gy in 1.8-2.0 Gy fractions using intensity-modulated RT plus chemotherapy (concurrent/sequential: 64%/36%) between 2004 and 2014. ECG abnormalities were classified as new Arrhythmic, Ischemic/Pericardial, or Non-specific (AΔECG, I/PΔECG, or NSΔECG ) events. Abnormalities were modeled as time to ECG events considering death a competing risk, and the variables considered for analysis were fractionation-corrected dose-volume metrics (α/β = 3 Gy) of ten cardio-pulmonary structures (aorta, heart, heart chambers, inferior and superior vena cava, lung, pulmonary artery) and 15 disease, patient and treatment characteristics. Each abnormality was modelled using bootstrapping and a candidate predictor was suggested by a median multiple testing-adjusted p-value ≤0.05 across the 1000 generated samples. Forward-stepwise multivariate analysis was conducted in case of more than one candidate. RESULTS: At a median of eight months post-RT, the rate of AΔECG, I/PΔECG, and NSΔECG was 66%, 35%, and 67%. Both AΔECG and I/PΔECG were associated with worse performance status (p = 0.007, 0.03), while a higher superior vena cava minimum dose was associated with NSΔECG (p = 0.002). CONCLUSION: This study suggests that higher radiation doses to the cardio-pulmonary system lead to non-specific ECG abnormalities. Reducing dose to this system, along with effective tumor control, is likely to decrease radiation-induced cardiac toxicity.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Hotca A, Thor M, Deasy JO, et al. Dose to the cardio-pulmonary system and treatment-induced electrocardiogram abnormalities in locally advanced non-small cell lung cancer. Clin Transl Radiat Oncol. 2019. PMID: 31650044. doi:10.1016/j.ctro.2019.09.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。